At present, the diagnosis and treatment of lung cancer have always been one of the research hotspots in the medical field. Early diagnosis and treatment of this disease are necessary means to improve the survival rate of lung cancer patients and reduce their mortality. The introduction of computer-aided diagnosis technology can easily, quickly, and accurately identify the lung nodule area as an imaging feature of early lung cancer for the clinical diagnosis of lung cancer and is helpful for the quantitative analysis of the characteristics of lung nodules and is useful for distinguishing benign and malignant lung nodules. Growth provides an objective diagnostic reference standard. This paper studies ITK and VTK toolkits and builds a system platform with MFC. By studying the process of doctors diagnosing lung nodules, the whole system is divided into seven modules: suspected lung shadow detection, image display and image annotation, and interaction. The system passes through the entire lung nodule auxiliary diagnosis process and obtains the number of nodules, the number of malignant nodules, and the number of false positives in each set of lung CT images to analyze the performance of the auxiliary diagnosis system. In this paper, a lung region segmentation method is proposed, which makes use of the obvious differences between the lung parenchyma and other human tissues connected with it, as well as the position relationship and shape characteristics of each human tissue in the image. Experiments are carried out to solve the problems of lung boundary, inaccurate segmentation of lung wall, and depression caused by noise and pleural nodule adhesion. Experiments show that there are 2316 CT images in 8 sets of images of different patients, and the number of nodules is 56. A total of 49 nodules were detected by the system, 7 were missed, and the detection rate was 87.5%. A total of 64 false-positive nodules were detected, with an average of 8 per set of images. This shows that the system is effective for CT images of different devices, pixel pitch, and slice pitch and has high sensitivity, which can provide doctors with good advice.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763488 | PMC |
http://dx.doi.org/10.1155/2022/7729524 | DOI Listing |
BMC Med Imaging
January 2025
Department of Radiology, Huadong Hospital, Fudan University, Shanghai, 200040, China.
Background: Interstitial lung abnormalities (ILA) are a proposed imaging concept. Fibrous ILA have a higher risk of progression and death. Clinically, computed tomography (CT) examination is a frequently used and convenient method compared with pulmonary function tests.
View Article and Find Full Text PDFSci Rep
January 2025
Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, 11461, Riyadh, Saudi Arabia.
Quantitative structure-property relationship (QSPR) modeling has emerged as a pivotal tool in the field of medicinal chemistry and drug design, offering a predictive framework for understanding the correlation between chemical structure and physicochemical properties. Topological indices are mathematical descriptors derived from the molecular graphs that capture structural features and connectivity, playing a crucial role in QSPR analysis by quantitatively relating chemical structures to their physicochemical properties and biological activities. Lung cancer is characterized by its aggressive nature and late-stage diagnosis, often limiting treatment options and significantly impacting patient survival rates.
View Article and Find Full Text PDFJ Mol Histol
January 2025
Department of Thoracic Surgery, Lung Cancer Diagnosis and Treatment Center of Dalian, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China.
Malignant tumors are among the major diseases threatening human survival in the world, and advancements in medical technology have led to a steady increase in their detection rates worldwide. Despite unique clinical presentations across the spectrum of malignancies, treatment modalities generally adhere to common strategies, encompassing primarily surgical intervention, radiation therapy, chemotherapy, and targeted treatments. Uncovering the genetic elements contributing to cancer cell proliferation, metastasis, and drug resistance remains a pivotal pursuit in the development of novel targeted therapeutics.
View Article and Find Full Text PDFInsights Imaging
January 2025
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Objectives: The aim of this study was to determine the status of tertiary lymphoid structures (TLSs) using radiomic features in patients with invasive pulmonary adenocarcinoma (IA).
Methods: In this retrospective study, patients with IA from November 2015 to March 2024 were recruited from two independent centers (center 1, training and internal test data set; center 2, external test data set). TLS was divided into two groups according to hematoxylin-eosin staining.
Nat Biomed Eng
January 2025
School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, Singapore.
The utility of urinary tests for the monitoring of the treatment efficacy and adverse events of anticancer therapies is constrained by the low concentration of relevant urinary biomarkers. Here we report, using mice with lung cancer and treated with chemotherapy, of a urinary fluorescence test for the concurrent monitoring of the levels of a tumour biomarker (cathepsin B) and of a biomarker of chemotherapy-induced kidney injury (N-acetyl-β-D-glucosaminidase). The test involves two intratracheally administered urinary reporters leveraging caged bioorthogonal click handles for the biomarker-dependent activation of 'clickability' and renal clearance, and the bioorthogonal click reaction of each renally cleared reporter with paired fluorescence indicators in the collected urine.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!